The finding that GLP-1 receptor agonists may be associated with a modest reduction in incident depression compared to DPP-4 inhibitors suggests that these agents could offer dual benefits providing effective glycemic control while also contributing to mood stabilization
It is metabolically active, supporting glucose disposal, stabilising blood sugar after meals, and maintaining insulin sensitivity
Many studies have reported risk factors and mechanisms associated with depression, but it is as yet unclear how these findings can be applied to the treatment and prevention of this disorder
We discuss a study documenting rising temperatures at the race over the decades, why the UCI's heat protocols are again under scrutiny, and what the Tour's own route designer says about how he is now choosing routes specifically for shadeUCI president Lappartient has floated the idea of reducing Tour de France team sizes from eight to six riders and introducing budget caps
Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: a pilot study
These studies provide evidence for the broader applicability and convenience of GLP-1 therapy in different patient populations
